|
Presiding Chairs
|
|
Chair:
|
Russell Weiner, Merck 
|
|
Chair-Elect:
|
Andy Vick, 7th Wave Labs 
|
|
REGULATED BIOANALYSIS
|
|
Chair: Chair-Elect:
|
Andy Vick, 7th Wave Labs Binodh DeSilva, Bristol-Myers Squibb
|
|
Committee:
|
Chris Evans, GlaxoSmithKline; Eric Woolf, Merck; Anne Aubry, Bristol-Myers Squibb; Johanna Mora, Bristol-Myers Squibb; Rick Steenwyk, Pfizer; Fumin Li, Covance; Farhad Sayyarpour, WIL Research, Yongjun Xue, Celgene
|
|
DISCOVERY BIOANALYSIS & NEW TECHNOLOGIES
|
|
Chair: Chair-Elect:
|
Ragu Ramanathan, BMS Jing-Tao Wu, Millennium/Takeda
|
|
Committee:
|
Chris Holliman, Pfizer; Mark Cancilla, Merck; Surinder Kaur, Genentech; Stephanie Pasas Farmer, Galleon; Silvi Chacko, Bristol-Myers Squibb; Pat Bennett, Thermo Scientific; Natasha Penner, Biogen Idec
|
|
BIOTRANSFORMATION
|
|
Chair: Chair-Elect:
|
Deepak Dalvie, Pfizer Chandra Prakash, Biogen Idec
|
|
Committee:
|
Tian Yang, Global Alliance for TB; Mark Milton, Novartis; Greg Walker, Pfizer; Rama Iyer, Bristol-Myers Squibb; Kirk Henne, Amgen; Cindy Xia, Millennium/Takeda, Hongbin Yu, Boehringer-Ingelheim
|
|